The HIV+Hepatitis Policy Institute, a non-profit organization, is very grateful for support from individuals, foundations, and corporations that invest in our mission to promote quality and affordable healthcare for people living with or at risk of HIV, hepatitis, and other serious and chronic health conditions. The HIV and Hepatitis Policy Institute is a 501(c)(3) tax-exempt organization. Donations to HIV+Hep are tax-deductible to the full extent allowed by law.
If you are interested in making a donation, please contact: Carl Schmid, Executive Director, at cschmid@hivhep.org.
1602B Belmont Street NW | Washington DC 20009
Facebook posts by @HIV+Hep
The hidden costs of co-pay assistance programs: How industry practices undermine patient access to medications: www.bioxconomy.com/access-and-channel/hiv-advocate-carl-schmid-warns-co-pay-accumulator-programs-...
Bipartisan House Group Pushes To Ban Copay Accumulators, Patient Group Separately Lobbies OMB: insidehealthpolicy.com/inside-drug-pricing-daily-news/bipartisan-house-group-pushes-ban-copay-acc...
Kean, Colleagues Introduce Bill to Protect Patients from High Prescription Drug Costs:
Kean, Colleagues Introduce Bill to Protect Patients from High Prescription Drug Costs
kean.house.gov
(December 4, 2025) WASHINGTON, DC – Today, Representatives Tom Kean, Jr.
Insurer Adds #HIV Treatments After Discrimination Complaints--Medica Improves Formularies in Iowa and Minnesota: bit.ly/3XyN9rQ
finance.yahoo.com
Nearly 1 in 5 People on PrEP in the United States Receive their PrEP through MISTR MISTR offers free online PrEP, STI Testing and HIV care A new study from Emory University, published today in the Jou...